# VFDB Category	MAG.T11.11	MAG.C2.12	MAG.T11.1	MAG.T11.14	MAG.T11.24	MAG.T11.25	MAG.T13.29	MAG.T11.57	MAG.T11.56	MAG.T13.20	MAG.T11.59	MAG.T11.72	MAG.T11.77	MAG.T12.26	MAG.T12.46	MAG.T12.69	MAG.T13.59	MAG.T13.57	MAG.T21.70	MAG.T22.48	MAG.T23.20	MAG.T22.49	MAG.T23.24	MAG.T13.85	MAG.T13.90	MAG.T22.36	MAG.T13.71	MAG.T13.60	MAG.T13.83	MAG.T21.30	MAG.T21.39	MAG.T23.60	MAG.T23.71	Description
VFC0001	5.0	3.0	5.0	3.0	10.0	4.0	9.0	3.0	15.0	5.0	4.0	6.0	2.0	12.0	6.0	5.0	8.0	5.0	3.0	3.0	3.0	6.0	4.0	3.0	5.0	15.0	5.0	4.0	5.0	7.0	9.0	7.0	4.0	 Adherence
VFC0086	1.0	1.0	0.0	1.0	0.0	0.0	6.0	0.0	8.0	0.0	0.0	1.0	1.0	3.0	0.0	3.0	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.0	1.0	0.0	0.0	0.0	0.0	4.0	2.0	1.0	 Effector delivery system
VFC0204	0.0	0.0	1.0	1.0	0.0	2.0	14.0	0.0	5.0	0.0	1.0	0.0	2.0	0.0	1.0	2.0	2.0	1.0	4.0	0.0	2.0	0.0	0.0	1.0	2.0	1.0	0.0	1.0	1.0	0.0	3.0	1.0	0.0	 Motility
VFC0235	0.0	1.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	 Exotoxin
VFC0251	0.0	1.0	0.0	0.0	1.0	1.0	1.0	2.0	1.0	0.0	1.0	1.0	1.0	1.0	1.0	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.0	0.0	1.0	0.0	1.0	2.0	2.0	0.0	0.0	 Exoenzyme
VFC0258	4.0	3.0	4.0	6.0	4.0	5.0	11.0	5.0	36.0	4.0	5.0	3.0	3.0	13.0	4.0	8.0	5.0	4.0	5.0	7.0	10.0	5.0	5.0	5.0	6.0	7.0	5.0	4.0	5.0	7.0	3.0	8.0	1.0	 Immune modulation
VFC0271	0.0	0.0	0.0	0.0	2.0	0.0	2.0	0.0	0.0	0.0	0.0	3.0	0.0	1.0	0.0	0.0	0.0	2.0	2.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	0.0	0.0	 Biofilm
VFC0272	1.0	1.0	1.0	0.0	0.0	1.0	2.0	0.0	35.0	0.0	0.0	3.0	0.0	4.0	0.0	0.0	0.0	2.0	3.0	4.0	7.0	0.0	0.0	0.0	8.0	2.0	2.0	1.0	1.0	1.0	4.0	0.0	0.0	 Nutritional/Metabolic factor
VFC0282	1.0	1.0	1.0	4.0	1.0	1.0	4.0	1.0	5.0	1.0	1.0	1.0	2.0	2.0	1.0	2.0	0.0	0.0	1.0	4.0	2.0	1.0	2.0	1.0	3.0	3.0	1.0	0.0	1.0	1.0	1.0	1.0	0.0	 Stress survival
VFC0301	0.0	0.0	0.0	2.0	1.0	0.0	0.0	1.0	24.0	0.0	0.0	1.0	1.0	1.0	0.0	0.0	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	8.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	 Regulation
VFC0315	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	 Post-translational modification
VFC0325	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	 Antimicrobial activity/Competitive advantage
VFC0346	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	 Others